Paul Loadman

Paul Loadman

University of Bradford

H-index: 46

Europe-United Kingdom

About Paul Loadman

Paul Loadman, With an exceptional h-index of 46 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Bradford, specializes in the field of Pharmacokinetics, Drug metabolism, Drug delivery, Cancer Pharmacology, Prodrug design.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in …

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp …

Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

Colorectal polyp outcomes after participation in the se AFO od polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use

Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

Paul Loadman Information

University

Position

Professor of Pharmacokinetics and Drug Metabolism

Citations(all)

6068

Citations(since 2020)

2300

Cited By

4899

hIndex(all)

46

hIndex(since 2020)

25

i10Index(all)

100

i10Index(since 2020)

57

Email

University Profile Page

University of Bradford

Google Scholar

View Google Scholar Profile

Paul Loadman Skills & Research Interests

Pharmacokinetics

Drug metabolism

Drug delivery

Cancer Pharmacology

Prodrug design

Top articles of Paul Loadman

Title

Journal

Author(s)

Publication Date

Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in …

Cancer Research

Udai Banerji

Natalie Cook

Alan Anthoney

Ruth Plummer

William D Tap

...

2024/4/5

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp …

International Journal of Cancer

Ge Sun

Harriett Fuller

Hayley Fenton

Amanda D Race

Amy Downing

...

2024/3/1

Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

Cancer Prevention Research

John R Davies

Tracey Mell

Harriett Fuller

Mark Harland

Rasha NM Saleh

...

2023/11/1

Colorectal polyp outcomes after participation in the se AFO od polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use

Alimentary Pharmacology & Therapeutics

Amy Downing

Hayley Fenton

Claire Nickerson

Paul M Loadman

Elizabeth A Williams

...

2023/9

Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial

Prostaglandins, Leukotrienes and Essential Fatty Acids

H Fuller

Amanda D Race

H Fenton

L Burke

A Downing

...

2023/5/1

Protocol: Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and …

BMJ Open

Mark A Hull

Pei Loo Ow

Sharon Ruddock

Tim Brend

Alexandra F Smith

...

2023

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues

Iscience

Francis M Barnieh

Sebastian P Galuska

Paul M Loadman

Simon Ward

Robert A Falconer

...

2023/11/17

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival …

BMJ open

Mark A Hull

Pei Loo Ow

Sharon Ruddock

Tim Brend

Alexandra F Smith

...

2023/11/1

Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells

Biochemical Pharmacology

Francis M Barnieh

Goreti Ribeiro Morais

Herbie Garland

Paul M Loadman

Robert A Falconer

2022/7/1

The role of MT1-MMP in the progression and metastasis of osteosarcoma

Hannah LM Spencer

Steven Shnyder

Paul Loadman

Robert A Falconer

2022

Cellular uptake and metabolism of MT1-MMP-activated taxane prodrugs

Cancer Research

Athina Polykandritou

Alexandra Serre

Hannah Spencer

Goreti R Morais

Amanda Race

...

2022/6/15

Cytochrome P450 binding and bioactivation of tumor-targeted duocarmycin agents

Drug Metabolism and Disposition

Aaron G Bart

Goreti Morais

Venu R Vangala

Paul M Loadman

Klaus Pors

...

2022/1/1

Intermittent PI3Ko inhibition sustains anti-tumor immunity and curbs irAEs

S Eschweiler

C Ramirez-Suastegui

Y Li

E King

L Chudley

...

2022/5/26

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Nature

Simon Eschweiler

Ciro Ramírez-Suástegui

Yingcong Li

Emma King

Lindsey Chudley

...

2022/5/26

A Single Short ‘Tone Burst’Results in Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic Microbubbles

Pharmaceutics

Nicola Ingram

Laura E McVeigh

Radwa H Abou-Saleh

Damien VB Batchelor

Paul M Loadman

...

2022/3/11

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Cancer Medicine

Ian S Miller

Sonja Khan

Liam P Shiels

Sudipto Das

Alice C O'Farrell

...

2022/10

Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4

Nanomedicine: Nanotechnology, Biology and Medicine

Antonia Charalambous

Victoria Mico

Laura E McVeigh

Gemma Marston

Nicola Ingram

...

2021/8/1

Immunomodulatory effects of PI3Kδ inhibition in solid tumors–evaluation in a randomized phase II trial

Christian Ottensmeier

Simon Eschweiler

Ciro Ramirez Suastegui

Emma King

Lindsey Chudley

...

2021/3/19

Methods of assessment of polysialyltransferase inhibitors for treatment of tumor cell dissemination

Cancer Research

Xiaoxiao Guo

Jodie R Malcolm

Anjana Patel

Marrwa M Ali

Goreti Ribeiro Morais

...

2021/7/1

Methods of treating cancer using compounds containing a vascular disrupting agent

2021/2/9

See List of Professors in Paul Loadman University(University of Bradford)